Endeavor

FDA Approves Rusfertide, Offering a New Option for Polycythemia Vera

For Danielle Sweet, the weekly injection helped end nearly four years of exhausting phlebotomy

New Drug Significantly Improves Outcomes for Patients with Polycythemia Vera

The therapy reduces the need for the therapeutic removal of blood and improves symptoms

Using Contemporary Data to Better Classify Blood Clot Risk in Polycythemia Vera Patients

Study shows age is less of a factor than medical history when it comes to risk for thrombosis

Drug Helps Control Iron Deficiency in Polycythemia Vera Patients

PTG-300 mimics the body’s main regulator of iron absorption